Texas launches largest state psychedelic research program in U.S. history
Texas ibogaine research just got a 0 million boost, marking the largest state-funded psychedelic research initiative in U.S. history. The Texas Legislature passed HB 3717 with bipartisan support, authorizing supervised clinical trials of ibogaine — a plant-derived compound long blocked by federal Schedule I classification — with a potential 00 million total investment when matched by a participating drug developer. The program prioritizes military veterans and first responders suffering from treatment-resistant PTSD and opioid addiction, populations with few effective options under current medicine. A landmark Stanford study found a single ibogaine dose reduced veteran disability ratings by 88 percent on average, making this funding a significant step toward mainstream clinical validation.









